Dose reduction of biologics in patients with plaque psoriasis: a review

In conclusion, DR seems promising, but a research gap still exists in randomized, prospective studies testing DR strategies, especially of IL-17/23i, hampering the completion of guidelines on DR. Taking into account the identified barriers and facilitators most likely results in a more successful implementation of biologic DR in practice.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research